Affordable Access

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.

Authors
  • Burdach, S1
  • Jürgens, H
  • Peters, C
  • Nürnberger, W
  • Mauz-Körholz, C
  • Körholz, D
  • Paulussen, M
  • Pape, H
  • Dilloo, D
  • Koscielniak, E
  • 1 Department of Pediatric Hematology/Oncology, Heinrich Heine Universität, Düsseldorf, Germany.
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
August 1993
Volume
11
Issue
8
Pages
1482–1488
Identifiers
PMID: 8101562
Source
Medline
License
Unknown

Abstract

Myeloblative therapy with hyper-ME +/- C radiochemotherapy can improve the prognosis of multifocal primary and early or multiple relapsing Ewing's sarcoma.

Report this publication

Statistics

Seen <100 times